Meagan Whisenant, PhD, RN
Assistant Professor
Department of Research
713-500-2005
儿子580e
meagan.whisenant@uth.tmc.edu
View Curriculum Vitae
Dr. Whisenant has worked in oncology nursing for more than 15 years, in both inpatient and outpatient settings. Dr. Whisenant completed a NINR T32 funded Postdoctoral Fellowship in Interdisciplinary Research in Cancer, Aging, and End of Life Care at the University of Utah, College of Nursing and a Hawn Foundation Postdoctoral Fellowship at The University of Texas MD Anderson Cancer Center Department of Symptom Research. Dr. Whisenant studies symptoms associated with cancer disease and treatment. Her work involves studying the measurement of cancer disease- and treatment-related symptoms, variability in symptom trajectories, and methods for implementing routine symptom monitoring and management in clinical care, including patient-reported outcomes (PRO) instrument development and testing. She utilizes both qualitative and quantitative methods to learn about the symptom experience from the patient and family caregiver perspective and consider approaches for monitoring and managing symptoms across the cancer trajectory.
Dr. Whisenant’s current focus is to improve cancer patient outcomes by developing a program of research focused on describing the symptom burden of cancer and methods for implementing routine symptom monitoring and management in cancer care using PRO measures. She is working on determining whether clinical, demographic, or genetic factors may distinguish symptom trajectory groups as well as modeling symptom trajectories in various cancer populations. Identifying distinct symptom trajectories and describing correlates of those trajectories may assist clinicians in targeting symptom management strategies for those most at risk for moderate or severe symptom experiences. Symptom monitoring and management has demonstrated improved cancer patient outcomes, yet best practices have not been established. Collection of symptom data is complicated by the dynamic nature of symptoms, the need for complex data management systems, and the timing of cancer symptoms, which often occur in the home setting and are not reported to clinicians. The use of disease-specific validated questionnaires in capturing PROs is critical for facilitating individualized symptom monitoring, management and treatment decisions. Dr. Whisenant is studying methods for capturing symptom-related data using PRO measures and studying patient-provider communication about symptoms in the outpatient setting.
Related News Items
出版：神经胶质瘤患者去世后的护理人员丧亲(May 2022)
Advancing HIV research and education(Apr 2022)
出版：使用大型全国EHR数据库的2型糖尿病的症状和症状簇表征(Mar 2022)
出版：乳腺癌接受治疗的妇女症状交流的分析(Dec 2021)
出版：接受汽车T细胞疗法的患者的独特症状负担(Dec 2021)
Publication: Identification of breast cancer survivors with high symptom burden(Dec 2021)
Cizik护理研究人员研究艾滋病毒阳性患者的症状beplay苹果手机能用吗管理（2021年10月）
出版：在CAR T细胞治疗后的头12个月内，患者报告的症状和功能状况（2021年9月）
Publication: Preferences of Individuals with Cancer for Patient-Reported Outcome Measures(Feb 2021)
Grant对癌症患者的COVIbeplay苹果手机能用吗D-19症状进行了研究(Aug 2020)
（出版物）非小细胞肺癌的患者经历了什么？MD Anderson症状清单的肺癌的内容域（2020年7月）
内部UTHealth
